We here report for the first time on the chemical characteristics of proteoglycans associated with mouse splenic reactive AA amyloid. Amyloid was induced in CBA/J mice by two different procedures; conventional casein treatment and by employing Freund's complete adjuvant, accelerated by Trypan Blue. Pulselabelling was employed at distinct stages during amyloid development, followed by [35S]proteoglycan characterization of organ extracts. Repetitive 35S injections were also administered during the phase where amyloid deposition occurred most rapidly. Proteoglycans were extracted with guanidine in the presence of protease inhibitors and purified. The results showed that the production of proteoglycans is dramatically enhanced, during amyloidogenesis, the glycosaminoglycan and proteoglycan accumulation being not only dependent on alterations in INTRODUCTION
INTRODUCTION
Amyloidosis is a group of disorders characterized by the deposition of amyloid in extracellular matrices. The unique component of amyloid is known to be the amyloid fibril; a proteinaceous rod of indefinite length with prominent fl-pleated sheet secondary peptide structure ['l,la] . During the last decade, evidence has been mounting that the association between sulphated -polysacoharides and amyloid is universal, i.e. glycosaminoglycans (GAGs) and proteoglycans (PGs) are co-deposited with amyloid fibrils in all kinds of amyloid studied so far [2J. Moreover, it seems clear that these events also occur coincidentally with an accumulation of other extracellular matrix-and basement-membrane (BM)-derived elements, such as collagen IV and laminin [3] , fibronectin [4] and vitronectin [5] . Employing immunohistochemical methodology, the appearance of the core protein of the large BM heparan sulphate (HS) PG (perlecan) has been reported for several amyloids [6] as well as a smaller vascular BM HSPG [7, 8] . In previous studies we have characterized biochemically GAGs and PGs derived from various human tissues afflicted with different amyloids [8] [9] [10] . A specific association between certain GAGs/PGs and purified amyloid fibrils has also been disclosed [10, 11] .
The aim of the present work was to isolate and characterize biochemically PGs/GAGs found in experimentally induced amyloid A (AA). Mouse experimental amyloidosis was chosen (serving as a suitable model for the investigation and understanding of the pathogenesis of amyloidosis), representing an equivalent to human secondary AA amyloidosis. The model offers the opportunity to avoid any post-mortem proteolysis, which might possibly explain why significant quantities of free proteoglycan catabolism, but rather on increased synthesis. The increment could be demonstrated even at the stage before microscopic detection of amyloid deposits, clearly suggesting that the upregulation of proteoglycan expression precedes amyloid fibril formation. Two major proteoglycans were found to accumulate in advanced splenic amyloid; one a heparan sulphate proteoglycan of approx. 200 kDa with a core protein of 70 kDa, the other a chondroitin sulphate proteoglycan of smaller size. Moreover, free dermatan sulphate chains seemed to specifically accumulate in the organs during amyloid fibrillogenesis. We suggest that free glycosaminoglycans may be a specific feature of amyl9idpsis, ais d that different proteoglycans and glycosaminoglycans play a role in formation and stabilization of amyloid fibrils in vivo.
GAG chains appear in a diversity of human amyloid preparations as previously described [11] . Thus, mouse splenic amyloid was employed as this particular organ is most severely afflicted with amyloid deposits, resembling the stage ofdisease found in affected human tissues at the time of autopsy. Moreover, an experimental animal model is far less material-consuming due to the possibility of in vivo GAG radiolabelling. Consequently, de novo synthesis of PGs could be analysed at different stages of amyloidogenesis. Additionally, repetitive radiolabelling during the phase of massive amyloid deposition would allow identification of which PGs and GAGs accumulate in the deposits. The mouse model has previously been employed in some studies addressing the association between GAGs/PGs and amyloid; however, most employed immunohistochemical and histochemical methods [6] which do not necessarily clarify the types and quantities of PGs actually present.
MATERIALS AND METHODS Materials
Na235SO4 (National Institute of Energy Research, Kjeller, Norway) was diluted with 0.9 % sterile saline. Liquid-scintillation cocktail (Ultima Gold XR) was purchased from Packard (Canberra, Australia). Casein (technical grade), aminohexanoic acid, N-ethylmaleimide, phenylmethanesulphonyl fluoride, Trypan Blue, thioflavine-T, calf thymus DNA, dinitropyridylalanine and chondroitin A were obtained from Sigma (St. Louis, MO, U.S.A.). Guanidinium chloride (Fluka, Buchs, Switzerland) was further refined by means of filtration through activated charcoal. Urea Laboratory animals Amyloid-susceptible CBA/J mice were chosen because attempts to induce amyloidosis in Balb/C mice did not succeed. 10-weekold inbred female mice (Charles Rivers, Wiga, Germany) were raised on pelletized feed (RM1-E, Special Diets Service, U.K.) and water ad libitum. The average weight of the animals and their spleens were 25 g and 90 mg respectively.
Amyloid Induction
Two different protocols were employed to induce amyloidosis in the animals. Saving time and effort, accelerated amyloidosis was induced in groups of mice by weekly subcutaneous injections of 0.3 ml of CFA emulsified in PBS in a 1: 1 (v/v) ratio. An aliquot (1.0 ml) of 1 mg/ml Trypan Blue in PBS was administered intraperitoneally one day before administering the first dose of adjuvant, serving as the enhancer in this protocol [1] [2] [3] .
Another group of 12 animals were subjected to a conventional amyloid induction protocol [14] receiving subcutaneous injections of 0.5 ml of 10% (w/v) casein in aq. solution, pH 7, for 5 days a week for a period of 14 weeks. The animals were all subjected to partial splenectomy after the tenth week to assess the degree of amyloid deposition in the tissue. No animals were lost during this procedure.
Biolabeiiing of PGs/GAGs
To analyse the de novo synthesis of sulphated polysaccharides, groups of 15 animals each were killed at different stages of accelerated CFA (aCFA)-induced amyloid deposition. Three animals in each group were given intraperitoneal injections of 75 MBq (2 mCi) of 35S 2 h before harvesting the spleens.
During the final 2 weeks of induction half of the animals subjected to both casein and aCFA treatments were given intraperitoneal injections of 35S (Na235SO4) to enable character- The animals were killed by cervical dislocation and the blood evacuated from the circulation by cardiotomy to prevent contamination of tissue PG extracts by polysaccharide components derived from serum. After removal from the animals, the organs were all immediately immersed in liquid nitrogen to prevent any post mortem proteolysis and kept frozen until subjected to further treatment. The procedures are summarized in Figure 1 .
Histological examination
Tissue specimens were immersed in 4 % buffered formaldehyde before paraffin embedding, sectioning and dewaxing and were subsequently subjected to standard haematoxylin-eosin, Congo Red [15] and thioflavine-T staining [16] .
Electron microscopy Following cervical dislocation, in situ fixation was performed on some animals. Briefly, infusion of 4 % formaldehyde in PBS was carried out through the left ventricle after opening the right atrium. Tissue specimens were further fixed in the same buffer, embedded in Epon, sectioned, stained and examined.
Alkaline phosphatase-anti-(alkaline phosphatase) (APAAP) was employed for immunohistochemical investigations. After sectioning and dewaxing, the tissue specimens were subjected to Pronase digestion for 8 24 h at 4 'C. The extract was subsequently subjected to trichloroacetic acid precipitation as previously described [18] , giving a significant decrease in the amount of contaminating proteins and nucleic acids [9] . Briefly, ice-cold 100% (w/v) trichloroacetic acid was added to the extract to give a final concentration of 10 % (v/v). Centrifugation was then performed and the supernatant neutralized dropwise with NaOH to pH 7. Ion-exchange chromatography The neutralized supernatant from trichloroacetic acid precipitation was extensively dialysed against 6 M urea/10 mM Tris/ HC1/10 mM EDTA/10 mM aminohexanoic acid with 0. 15 M NaCl, pH 5.8, at 4 'C. The material was then subjected to DEAE-Sepharose ion-exchange chromatography, essentially as described elsewhere [9] . The runs were carried out at 4 'C. Samples (100-250 ,1) from each fraction were mixed with 2-3 ml of liquid-scintillation cocktail before counting. Measurements of absorbance at 280 nm, as well as conductivity in each fraction, were also performed.
Detection of GAGs
The DMB colorimetric assay for sulphated GAG quantification according to Farmdale et al. [19] was performed in order to determine the elution profile of the total [PG/GAG] in extracts eluting from ion-exchange chromatography gels.
PG/GAG characterization
Pooled fractions from the DEAE ion-exchange chromatography were extensively dialysed against cold distilled water and lyophilized. Alternatively, peak fractions were distributed as 500,ul aliquots, desalted on a prepacked Sephadex G-25 column (PD10) and subjected to vacuum-concentration before further characterization. Various enzymic and chemical treatments were carried out as follows: chondroitinase ABC, chondroitinase ACII and chondroitinase B (dermatanase) digestions were performed at 37 'C for 15 h [20] and heparitinase digestion at 40 'C. Depolymerization of heparan sulphate was also done by low-pH nitrous acid treatment as previously described [21] . f-elimination was performed by 24 h incubation with 0.05 M NaOH in 1.0 M NaBH4 at 45 'C [22] .
Gel filtration
Gel filtration was performed on a 0.8 cm x 95 cm Sepharose CL-6B column eluted with 6 M urea/ 10 mM Tris/HCl/0.5 M NaCl, pH 5.8; a 1.0 cm x 50 cm Sepharose CL-2B column eluted with the same buffer; a prepacked PD-10 Sephadex G-25 column and 4 cm3 Sephadex G-50 fine columns, eluted with cold distilled water. Calibration of the CL-6B column was performed as described elsewhere [10] . All runs were performed at 4 'C.
Electrophoresis
Phase System (Pharmacia) was employed for small-size SDS/ PAGE. Materials obtained from ion-exchange chromatography were subjected to Sepharose CL-6B gel filtration followed by desalting on PD-10 columns and lyophilization. The samples were subsequently prepared and run as previously described [8] . Long (25 cm) ultrathin (0.5 mm) 3-12 % (w/v) polyacrylamide gels with 3 % stacking gels were cast on GelBond PAG films using the Laemmli buffer system [23] and run horizontally with ExcelGel bufferstrips on constant current. The gels were subsequently fixed and stained with 0.2 % Coomassie Blue/0. 1 % Alcian Blue followed by silver staining with preceding oxidation [24, 25] .
Western blotting Semi-dry electrophoretic transfer to nitrocellulose membranes was performed following SDS/PAGE [26] . After 24 h incubation in blocking solution [3 % (w/v) gelatin in Tris-buffered saline, pH 7 .5] and incubation with primary anti-HSPG antibodies for 16 h, alkaline phosphatase-conjugated rabbit anti-(mouse IgG) at 1: 1000 dilution was added and incubated for 1 h. Development was carried out with NN-dimethylformamide containing 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and Nitrobluetetrazolium chloride (NBT) [27] .
RESULTS

Animals and organs
The total weight of the amyloidotic animals varied between 30 and 36 g. The average masses of the organs derived from the aCFA-induction protocol, at different stages, are shown in Table 1 .
Histological examination Significant hyperplasia and cellular infiltration was apparent in splenic sections taken from mice 2 days after aCFA-induced acute-phase reaction. No amyloid deposits could be detected by Table 1 , the synthesis of GAGs/PGs after 2 h of radiolabelling at the different stages of amyloidogenesis is demonstrated relative to the incorporation in normal control animals. The incorporation of 35S in GAGs was increased approx. 6-fold even before microscopic amyloid deposition occurred (pre-amyloid phase). The same level of synthesis was detected after 10 days (early amyloid phase). The production of sulphated polysaccharides was increased even more, approx. 12-fold (35S-labelled material relative to splenic mass), in the advanced stages of amyloidosis (8, 10 and 13 weeks respectively).
Ion-exchange chromatography
Ion-exchange chromatograms of splenic extracts obtained from in vivo 35S incorporation for 2 h at distinct phases of amyloidogenesis ( Figure 3a ) and normal spleens (Figure 3c ), exhibited a similar elution pattern. However, the total amounts differed ( Table 1 ). The amount of material eluting in peak 2 comprised 10-150% of the total material. DMB analysis of the amyloidderived material eluting from the gel (Figure 3a) revealed a difference between the total accumulated material and that synthesized de novo. Notably, the peak 2: peak 1 ratio increased significantly when GAGs were detected by DMB analysis versus 35S measurements. Materials derived from casein-treated mice eluted as two peaks; the first (peak 1) appearing polydispersely at 0.67 M NaCl, and the second (peak 2) eluting at 0.75 M NaCl (Figure  3b ), an elution pattern resembling that previously found for a variety of human amyloids [8] . The corresponding normal control extracts also eluted as two peaks, peak 1 at a slightly lower ionic strength (0.63 M NaCl) (Figure 3c ). However, the relative amount of 35S-labelled material eluting in the respective peaks varied when comparing the amyloidotic and normal tissue extracts. Peak 2 approximated to 420% of the total amyloidderived material, as contrasted to 250% of the total material obtained from the normal control extract (Figure 3c) . Notably, peak 2 from aCFA-treated mice, subjected to repetitive radiolabelling, contained significantly less material (approx. 20 %) than the corresponding peak from casein treatment.
DEAE-Sepharose peak 1-derived polysaccharldes 35S pulse-labelling
On Sepharose CL-6B it was demonstrated that about half of the material (Figure 3a normal controls, a relatively higher amount of the HS fraction occurred as PGs, a feature not exhibited with the amyloidderived extracts.
Accumulated 35S-labelling
The galactosaminoglycans in peak-1 aliquots from severely amyloidotic spleens (Figure 3b ) eluted as two major peaks on gel
DEAE-Sepharose peak 2-derived polysaccharides
Polysaccharides from amyloidotic animals, radiolabelled for 2 h or repetitively for 2 weeks (Figures 3a and 3b ), eluted as one main peak at Kav 0.41 on Sepharose CL-6B (Figure 5a ). Following flelimination the Kav did not change. When subjected to chondroitinase ABC, all of the material depolymerized whereas chondroitinase ACII treatment revealed a relatively low enzyme susceptibility ( Figure Sb) . Chondroitinase B treatment of this material is displayed in the same panel, showing the appearance of relatively long digestion fragments in addition to oligo-and disaccharides, indicating the presence of a dermatan sulphate (DS)/CS co-polymeric structure. The corresponding material obtained from normal controls, pre-amyloidotic tissue and early-phase amyloid had the same size as that from massive amyloid deposits (Kav 0.41) and depolymerized upon chondroitinase ABC treatment (results not shown). However, the free GAGs were less resistant to chondroitinase ACII treatment (Figure 5c ). Also, elution patterns of chondroitinase-digested normal control preparations disclosed the similarity with the DS/CS chains found in the pre-amyloidotic and early amyloid deposition phase (not shown). However, the GAG chains obtained from repetitive radiolabelling of the normal controls appeared to have a significantly reduced molecular mass (Ka, 0.55) (Figure 5d ) when compared with those obtained from amyloidotic extracts, as well as normal preparations obtained after 2 h of 35S pulse-labelling (Kav 0.41).
In Table 2 
SDS/PAGE and Western blotting
Materials eluting in peak 1 after DEAE-Sepharose isolation of casein-induced amyloidotic spleens (Figure 3b) were run preparatively on a Sepharose CL-6B column, and the PG fractions pooled, exhaustively dialysed, lyophilized and subjected to SDS/ PAGE. Electrophoresis of materials recovered after Sepharose CL-6B gel filtration revealed one major PG with molecular mass 180-190 kDa, as well as a smear with extremely disperse migration characteristics (Figure 6a, lane 1) . Following chondroitinase ABC digestion all of the latter disappeared, leaving the HSPG (lane 2). The DS preparation obtained from HNO2 
Summary
Using in vivo radiolabelling, amyloidogenic stimulation clearly increased the synthesis of splenic PGs. This increment appeared before fibril deposition. Galactosaminoglycans accounted for 70-80 % of splenic PG/GAG synthesis at the different stages of amyloid formation. In normal, pre-amyloidotic and early-phase amyloidotic organs, the labelled polysaccharides appeared mainly as free GAG chains, indicating a very rapid turnover of PGs in splenic tissue. In severely amyloidotic tissue, however, the presence of significant quantities ofintact PGs was demonstrated. The PGs were a 200 kDa HSPG with a 70 kDa core protein and a smaller CSPG respectively. Using multiple 35S injections, it appeared that free, relatively high-molecular-mass DS/CS chains accumulated in the tissue during amyloid deposition, and that their co-polymeric structure changed in the course of amyloidogenesis, favouring DS structure.
DISCUSSION
In the present investigation, [35S]polysaccharides, pulse-labelled in vivo, were extracted from mouse spleens at different stages during the course of reactive amyloidogenesis. In addition, repetitive 35S injections were administered during the period when most of the amyloid was deposited, providing the opportunity to characterize the PGs and GAGs accumulating in amyloid. Exhaustive induction protocols were employed with intent to obtain seriously afflicted tissues, mimicking the pathology of those observed in humans dying from advanced AA amyloidosis [8, 9] .
It seems that normal splenic tissue exhibits a very rapid turnover of PGs as only very limited amounts of intact PGs could be traced. Consequently, it is possible that PGs are synthesized and almost immediately internalized or shedded and decomposed, thus releasing free GAG chains. The distribution between galactosaminoglycans and glucosamines was approx. 3: 1 for both amyloidotic and normal control organs (Table 2) , a proportion which has been suggested previously [29] . Moreover, splenic parenchyma do not contain much extracellular matrix/ connective tissue, although haematopoietic and immunological cells, which are known to synthesize and contain CS/DS, are abundant [30] .
In extracts of heavily amyloidotic spleens two principal PG populations appeared to be produced and accumulated. First, a small CSPG was found in advanced amyloid. Secondly, a 200 kDa HSPG occurred, possessing a core protein of 70 kDa and HS chains of about 30 kDa. The molecular mass is approximately the same as the (bovine vascular) BM HSPG [31] and those previously isolated from various human amyloids, which have core proteins displaying immunological identity [8, 9] . Moreover, neuroblastoma-derived DSPGs and HSPGs of identical size also seem to cross-react immunologically [32] , suggesting the presence of closely related core protein which may be substituted with either HS or DS/CS residues. Definite conclusions should not be drawn as to the nature of this HSPG as none of the antisera in this study reacted with the core protein on Western blots. However, to our knowledge no reports have previously been carried out aimed at a biochemical characterization of PGs derived from splenic tissue, regardless of species, so the PG might even represent a hitherto undescribed molecule.
Free DS chains obviously accumulate in amyloid deposits, comprising about 40 % of the accumulated 35S-labelled macromolecules, and hence exceeding the amount synthesized at different stages during amyloid development, as well as that accumulating in normal spleens. However, the DS/CS: HS ratio did not differ significantly in normal and amyloidotic spleens ( Table 2 ), indicating that increased epimerase activity might also be involved during development of reactive amyloidosis. Some variation in DS quantity, comparing preparations from adjuvantand casein-treated animals, could depend on real differences in GAG distribution due to different stimuli. However, most of the amyloid deposited in casein-challenged mice occurred after 10 weeks, as verified by partial splenectomy. Thus it seems plausible that the observed variations might also reflect different phases of amyloid deposition.
Noteworthy, the results are in agreement with those obtained with various human amyloids [8] [9] [10] [11] , indicating that free DS/CS chains are major polysaccharide components ofamyloid deposits. Moreover, the occurrence of highly sulphated DS during amyloidogenesis has previously been described for Balb/C mice [33] .
Also, the presence of free GAG chains, especially in cell cultures, has been reported [34] .
Several investigators have failed to detect CSPG/DSPGs in amyloid deposits by immunohistochemistry [8, 35, 36] . Intriguingly, the sole exception is the presence of anti-decorin immunostaining in the peripheries of Alzheimer's ,i-amyloid [37] , which might support the hypothesis that DSPGs are co-deposited with amyloid fibrils initially, subsequently releasing free DS chains which strongly associate with the fibrils. In the present investigation, only a minute fraction of the total material had a molecular mass comparable with that of intact perlecan [38] . Although this low-density BM HSPG has previously been reported to be converted into a high-density variant [39] , the present results, as well as preliminary results utilizing shorter labelling intervals, do not suggest that the present HSPG is derived from a larger precursor.
The fact that smaller HSPG variants appeared in the normal, pre-amyloidotic and early-phase amyloidotic tissue extracts might be explained by partial degradation of HSPGs, a process which seems to be more rapid in the normal state. It might also be a reflection of altered synthesis during disease resembling the effects of transforming growth factor-,8 stimulation on cultured cells, hence producing larger PGs [40] .
The significance of PGs in amyloid fibrillogenesis is still poorly understood. Such molecules definitely accumulate during disease development, but the present work shows for the first time evidence that the in vivo production of sulphated polysaccharides is actually enhanced. Thus, it seems that increased GAG quantities in amyloids do not merely depend on a passive accumulation depending on an altered catabolism of PGs. The results thus support the work of Linker and Carney [29] who reported an increased 35S incorporation in GAGs obtained from cultures of tissue slices of amyloidotic versus normal organs. The fact that the increased PG synthesis actually precedes the deposition of amyloid fibrils in the extracellular matrix is also suggested from previous histochemical investigations [41] in addition to the recent demonstration that perlecan gene expression is enhanced before amyloid formation [42] . The potential significance of such carbohydrates for amyloid formation is suggested by the conformational effect ofGAGs on the mouse amyloid fibril precursor protein, SAA 2 [43] . Furthermore, HSPGs and laminin strongly interact with the ,-protein precursor [44, 45] , and sulphate ions are shown to induce conformational changes for both the ,-protein [46] and SAA-derived fragments [47] .
To conclude, it thus seems that extracellular matrix elements, and especially PGs/GAGs synthesized in situ, may impart fibrillogenic and/or fibril-stabilizing properties during fibril deposition. We believe that the polysaccharides may take an active part in the anchoring of fibril protein precursors to the site of deposition and their conversion into an insoluble fibrillar form.
